Uncategorized
Hereditary cancers aren’t just a women’s problem. Jewish men need to take precautions too.
Bill Harris, a veteran Los Angeles photojournalist, didn’t think much of it when one morning in 2012 he woke up and found a tiny blood spot on the T-shirt he’d slept in. The next morning, he found blood in the same place on his chest — and went straight to his computer.
“Online, I could find only three things that would cause a man’s nipple to discharge blood: being an avid runner, which I wasn’t; having a subtropical fungus, which I didn’t; and breast cancer,” he said. “That was a pretty big shock.”
Harris, then just a few weeks shy of his 61st birthday, immediately called his doctor, who ordered a mammogram and ultrasound. They confirmed a cancerous growth in his right breast. Ten days later, a biopsy came back positive. The next month Harris got a right mastectomy, followed by the removal of his left breast half a year later.
“I walked into a woman’s imaging center and had to get into a pink paper robe,” he recalled. “All the women in the waiting room were staring at me.”
Like many other Ashkenazi men, Harris never had considered that he might have been born with a harmful mutation of the BRCA gene, which elevates the risk not only of breast cancer, but also of melanoma and prostate, ovarian and pancreatic cancer.
“Hundreds of other mutations in the BRCA gene are just as dangerous, but they’re not specific to Ashkenazim,” said Dr. Robert Sidlow, director of the Male BRCA Genetic Risk Program at New York’s Memorial Sloan Kettering Cancer Center. About 1 in 40 Ashkenazi Jews (those of Eastern European descent) carries the harmful mutation, compared to about 1 in 400 in the general population.
“The vast majority of patients I see are relatives of women who have breast or ovarian cancer and then get tested,” he said. Of BRCA mutation carriers, Sidlow added, “Most men are pretty happy to enroll in some kind of surveillance program once they get over the initial shock.”
Sidlow is on the Men’s Leadership Council at Sharsheret, the national Jewish nonprofit organization that educates the community about cancer risks and supports those with breast cancer and ovarian cancer.
Elana Silber, CEO of Sharsheret (Hebrew for “chain”), says it’s crucial that men with a family history of cancer undergo genetic counseling screening for BRCA and other hereditary cancer mutations.
Genetic testing is possible via a standard blood or saliva sample.
While Sharsheret is primarily considered a women’s organization, it has been using November — nicknamed Movember for its focus on men’s health — for an awareness campaign focused on Jewish men’s cancer risks.
“This is not only a women’s issue,” Silber said. “Family history is so important. When a man shares his family history with his doctor, he may not realize that he should mention that his mother had breast cancer or that his sister had ovarian cancer, as these are not generally ‘men’s diseases.’ They are not aware that these cancers could mean that they themselves are at increased risk for cancer and that they can pass on these mutations to the next generation – their daughters and their sons.”
If someone discovers he (or she) is a carrier of one of the genetic mutations with elevated cancer risks — not just BRCA but also such mutations as ATM, TP53, CHEK2, and PALB2 — there are various precautions they can take for themselves and their children. They can monitor their own health more closely, they can get encourage their children to test to see if they are carriers and, for any future children, take steps to prevent the mutated genes from being passed down.
For example, couples can conceive via in vitro fertilization, or IVF, and then test the embryos before implantation to ensure that only those unaffected by the genetic mutation are implanted.
While most women are aware of the risks of breast cancer, men generally are not — even though the disease strikes 2,500 men in the U.S. every year and kills about 500 of them, according to Sidlow. About 1-2% of men with the BRCA1 mutation and 6-7% of men with the BRCA2 mutation will develop cancer by age 80.
“This is why we recommend periodic mammograms starting at about age 50 for men who carry a BRCA2 mutation,” Sidlow said. “We like to educate these men on how to check their chests once a month and have a clinician do a breast checkup on them once a year.”
Since the BRCA1 and BRCA2 mutations also make prostate cancer more likely, men with either mutation should get PSA (prostate-specific antigen) levels in their blood tested annually beginning at age 40, rather than 50, the age at which screening generally begins, Sidlow said.
Sharsheret has been promoting the importance of learning one’s family history, genetic counseling and screening among both men and women. The 20-year-old organization also runs various peer support networks, offers financial assistance to cancer patients, provides mental health counseling and guidance to patients, caregivers, and their friends, and seeks to educate the broader Jewish community about cancer risks and support.
Peggy Cottrell, a certified genetic counselor at Sharsheret, said men in general are more reluctant to get regular checkups than women.
Ashkenazi Jewish men are at elevated risk not just of breast and prostate cancer but also of pancreatic cancer. Pancreatic cancer is particularly difficult because it’s tough to detect early enough and hard to treat. The five-year survival rate is only 11%. About 2% of BRCA1 carriers and 4% of BRCA2 carriers will develop pancreatic cancer, Sidlow estimated.
“Usually by the time pancreas cancer is clinically detected it has already spread microscopically to the liver,” Sidlow said. “But pancreas cancer is potentially curable if caught when the tumor is extremely small.”
Even among those with elevated risks, certain behaviors can improve one’s odds, such as avoiding obesity, smoking and excessive alcohol consumption.
Harris, the California photojournalist, is still fighting at age 71. While he overcame breast cancer 10 years ago, last year he was diagnosed with ampullary cancer, a rare disease related to his BRCA2 status that was discovered thanks to his participation in a UCLA study. Surgeons have removed his gall bladder, half his pancreas and part of his small intestine, and he has had to endure eight rounds of chemotherapy.
“I’m still working through the aftereffects of the chemo. I have to eat smaller quantities than before and take enzymes to supplement my digestive processes,” Harris said.
Meanwhile, his 37-year-old son discovered that he, too, carries the BRCA2 mutation, and he had a double prophylactic mastectomy and reconstruction at age 30 — just to be on the safe side.
“If there’s any history of breast, ovarian or prostate cancer in your family, get tested genetically so that you’re informed,” Harris advised. “Diagnoses happen way too late for men, and the danger is too big.”
—
The post Hereditary cancers aren’t just a women’s problem. Jewish men need to take precautions too. appeared first on Jewish Telegraphic Agency.
Uncategorized
Iran appoints AMIA bombing suspect to National Security Council
(JTA) —
For the second time this year, Iran has named a wanted suspect in the 1994 bombing of the AMIA Jewish community center in Buenos Aires to a top security role.
A spokesman for the Islamic Republic’s president, Masoud Pezeshkian, said Monday that Mohsen Rezaei had resigned as an adviser to the supreme leader, Ayatollah Mojtaba Khamenei, and would assume the role of secretary of Iran’s powerful Supreme National Security Council. Rezaei is a former commander of the Islamic Revolutionary Guards Corps.
Rezaei is wanted by Argentina and is subject to an Interpol Red Notice issued at Argentina’s request over his alleged role in the 1994 attack, which killed 85 people and remains the deadliest terrorist attack in Argentina’s history.
Earlier this year, Ahmad Vahidi, another suspect in the AMIA case and also the subject of an Interpol Red Notice, was appointed IRGC commander.
In a landmark ruling in 2024, an Argentine court held Iran and its proxy in Lebanon, Hezbollah, responsible for the bombing, setting the stage for international legal action.
In June 2025, Argentina’s federal judiciary ordered that 10 Iranian and Lebanese suspects accused in connection with the deadly 1994 AMIA bombing be tried in absentia. Rezaei and Vahidi are among them.
The eight other suspects accused by the late AMIA special prosecutor, Alberto Nisman, are: former Iranian Intelligence Minister Ali Fallahijan, former Iranian foreign minister Ali Akbar Velayati, former Iranian ambassador Hadi Soleimanpour, former Iranian cultural attache in Buenos Aires Mohsen Rabbani and former Iranian diplomat Ahmad Reza Asghari, as well as suspected Hezbollah operatives Salman Raouf Salman, Abdallah Salman and Hussein Mounir Mouzannar.
The post Iran appoints AMIA bombing suspect to National Security Council appeared first on The Forward.
Uncategorized
Israel and AIPAC on the ballot in the Minnesota Senate and U.S. House races
(JTA) — A pair of Democratic primaries in Minnesota on Tuesday are among a string of high-profile battles between progressive and moderate candidates, where Israel and the pro-Israel lobby serve as key wedge issues.
The state’s highest-profile race is the U.S. Senate primary between Rep. Angie Craig, who has been endorsed by the pro-Israel lobbying group AIPAC, and Lieutenant Gov. Peggy Flanagan, who says she would reject AIPAC’s money and accuses Israel of committing a genocide.
The most recent data gathered in late July through early August has Craig with a 2-percentage point lead, within the 5.3% margin of error. Another poll, conducted in late July by a group supporting Flanagan, shows her with a 14-point lead. The Democratic nominee, whether it be Flanagan or Craig, is expected to win the general election in November.
The race, and the candidates’ sparring over AIPAC, comes as the lobby and Israel under the leadership of Prime Minister Benjamin Netanyahu have become increasingly unpopular among Democratic voters. Israel is also an issue in the Democratic gubernatorial primary in neighboring Wisconsin taking place on Tuesday.
Flanagan has referred to Craig as “AIPAC’s candidate” in the Senate race, which prompted Craig to distance herself from the group’s spending during a TV debate in June.
“AIPAC has not contributed at all, the PAC, to my Senate campaign,” said Craig, whose wife, Cheryl Greene, is Jewish. “Not one penny.”
Flanagan countered that, while AIPAC itself has not donated to Craig’s campaign, it has held fundraisers for the four-term congresswoman. AIPAC did not respond to a request for comment.
Just last week in Michigan’s Democratic Senate primary, progressive Abdul El-Sayed defeated the moderate Rep. Haley Stevens, whose AIPAC endorsement was the frequent target of opposition attacks.
Flanagan has drawn the support of American Priorities, a pro-Palestinian super PAC that aims to counter AIPAC. The group spent about $54,000 on ads boosting her candidacy, according to FEC filings.
Flanagan’s platform includes blocking offensive weapons sales to Israel — a position that all but seven Senate Democrats voted for in April — and advancing a two-state solution that “allows for a secure Israel and Palestinian self-determination.”
Craig, who also backs a two-state outcome, voted against the recent amendment proposed by Kentucky Rep. Thomas Massie that would have halted $3.3 billion in military aid to Israel.
In a statement explaining her vote, Craig panned Netanyahu and the war in Iran, but wrote that the amendment would endanger Israelis and American troops and allies in the region. After the vote, Flanagan wrote, “A vote to send $3.3 billion of taxpayer money to fund additional weapons of war to Benjamin Netanyahu is unconscionable. Enough.”
Craig has the endorsement of a number of Democrats in Congress and the Senate, including House Minority Leader Hakeem Jeffries. She is also endorsed by lobbying group Democratic Majority for Israel, former Democratic presidential contender Pete Buttigieg, and Minneapolis’ Jewish mayor, Jacob Frey, who rose to national prominence for his response to the deadly results of the deployment of immigrant enforcement officials in his city.
Flanagan has drawn endorsements from a swath of major progressive figures including Vermont Sen. Bernie Sanders, Massachusetts Sen. Elizabeth Warren, and outspoken pro-Palestinian Reps. Ro Khanna of California and Ilhan Omar of Minnesota. Flanagan is also endorsed by the state’s Democratic Party affiliate, the Democratic Farmer Labor Party.
On Sunday Sanders posted on X,”There is a reason why the super PACs and billionaires are flooding Minnesota with $20 million to defeat Peggy Flanagan. Same thing as Michigan. They do not want somebody in the Senate who will stand up for the working class.”
Spending by political action committees affiliated with AIPAC has also come to the fore in the Democratic primary race for the House seat that Craig is vacating.
The most moderate of the three leading candidates is State Sen. Matt Klein, who has expressed support for the U.S.-Israel relationship and is endorsed by DMFI. Last-minute spending by outside groups has sparked accusations that AIPAC is indirectly involved.
“AIPAC is coming after me,” said former Lakeville mayor Matt Little, one of Klein’s opponents, in a video.
Klein’s two opponents — Little and state Rep. Kaela Berg — both accuse Israel of committing a genocide, and have both speculated that AIPAC is behind some of the Klein spending.
Berg supports placing conditions on U.S. aid to Israel and halting weapons sales, and Little says the U.S. must end all military aid and weapons sales to the country. On the policy page of his campaign website, Little refers to Hamas’ Oct. 7 attack as “an act of wanton slaughter against innocent civilians” and says that people should condemn “the anti-Semitism that followed.”
Berg is listed as “primary approved” by the liberal Jewish Middle East advocacy group J Street, while Little has been boosted by American Priorities, which has spent about $64,000 in his favor. He is also endorsed by the DFL and Congressional Progressive Caucus leader Rep. Pramila Jayapal.
The latest polling in the district — conducted at the end of May by a group that favors Klein — found Little leading Klein with a 7-percentage point lead, and Berg trailing by another 3 points. 39 percent of voters were undecided, and Little and Klein were about even after voters received more information about the three candidates.
Craig has declined to endorse any of the candidates to replace her.
The post Israel and AIPAC on the ballot in the Minnesota Senate and U.S. House races appeared first on The Forward.
Uncategorized
Sister of pro-Israel stalwart Lindsey Graham wins runoff slot
(JTA) — South Carolina Sen. Darline Graham and a second Republican candidate will advance to a special primary runoff in two weeks, when voters will decide which GOP candidate might take the vacant seat of her late brother Lindsey Graham.
Just over an hour after polls closed, at about 8:15 pm, the Associated Press declared that Darline Graham would advance to a runoff election, noting that “one additional candidate will also advance.” At that point Graham had secured 32.6% of the vote, with 39% of ballots counted.
Graham was up against nine fellow Republicans, with her biggest competition including U.S. House Reps. Ralph Norman and Russell Fry, who were closely vying for the second spot in the runoff at the time of the AP’s call. In South Carolina, the top contender would have needed to win a majority of votes in order to avoid the two-candidate runoff, scheduled for August 25.
In the November general election, the winner will face Democrat Annie Andrews, a pediatrician who is unlikely to prevail in this solidly Republican state.
Tuesday’s race marked the second time in two months that GOP voters came to the polls to select a Senate candidate, and now they will need to do so a third time. Longstanding Sen. Lindsey Graham, a top ally of Israel in the U.S. Senate and supporter of military action against Iran. won the original primary in June but died suddenly from an aortic dissection on July 11.
Graham, who was 71 years old, served 23 years in the Senate and eight in the U.S. House. He was a member of the Senate’s Armed Services and Budget committees and had traveled to Israel about a dozen times since Hamas’s Oct. 7, 2023 attack on Israel.
Heading into Tuesday’s primary, analysts expressed no doubt that the winner would be pro-Israel. They stressed, however, that matching Graham’s level of foreign policy experience and focus on Israel, a place he often visited, would be a formidable task.
“Whoever wins this is going to be an ally of Israel,” Christopher Cooper, a political science professor at Western Carolina University, told the Jewish Telegraphic Agency in the lead-up to the race. “The question is whether they will be the champion for Israel that Lindsey Graham was.”
A few days after Graham’s death, South Carolina Gov. Henry McMaster, a Republican, appointed Darline Graham to complete the late senator’s term. Despite having minimal policy experience, such as a past role on the South Carolina Commission for the Blind, she earned President Trump’s support and soon declared her candidacy in the full race.
While 10 candidates were running in the Tuesday primary, only about two others were considered serious competition for Graham, Norman and Fry: businessman Mark Lynch and Mark Sanford, whose governorship was plagued with scandals and who briefly ran against Trump in the 2020 presidential primaries.
The post Sister of pro-Israel stalwart Lindsey Graham wins runoff slot appeared first on The Forward.
